Abstract
Strongyloides stercoralis, the causative agent of strongyloidiasis, is an intestinal nematod classified in the genus Strongyloides. The latter are plasmids widely distributed as intestinal parasites in mammals. S. stercoralis (known also as S. intestinalis, Anguillula intestinalis, A. stercoralis) is a roundworm occuring mainly in tropical and subtropical countries (1). In the U. S., strongyloidiasis is endemic in certain southern regions (eastern Kentucky, Tennessee, Lousiana, and southern Appalachia) (2–4), although cases have been reported in all major geographic areas of the country (2,3,5–18), with fatal outcomes being reported in malnourished children from socioeconomically deprived circumstances (13,19,20).
Chapter PDF
Keywords
- Adult Respiratory Distress Syndrome
- Immunosuppressed Patient
- Lepromatous Leprosy
- Tuberculoid Leprosy
- Hyperinfection Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Genta, R. M. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev. Infect. Dis, 11, 755, 1989.
Fulmer, H. S. and Huempfner, H. R. Intestinal helminths in eastern Kentucky: a survey in rural counties. Am. J. Trop. Med. Hyg, 14, 269, 1965.
Ophüs, W. A fatal case of strongyloidiasis in man, with autopsy. Arch. Pathol, 8, 1, 1929.
Berk, S. L., Verghese, A., Alvarez, S., Hall, K., and Smith, B. Clinical and epidemiologic features of strongyloidiasis: a prospective study in rural Tennessee. Arch. Intern. Med, 147, 1257, 1987.
Scowden, E. B., Schaffner, W., and Stone, W. J. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore), 57, 527, 1978.
Igra-Siegman, Y., Kapila, R., Sen, P., Kaminski, Z. C., and Louria, D. B. Syndrome of hyperinfection with Strongyliodes stercoralis. Rev. Infect. Dis, 3, 397, 1981.
Pollock, T. W. and Perencevich, E. N. Hyperinfection with Strongyloides stercoralis in a patient with Hodgkin’s disease. J. Am. Ostheopath. Assoc, 76, 171, 1976.
Rogers, W. A. Jr. and Nelson, B. Strongyloidiasis and malignant lymphoma:“opportunistic infection” by a nematode. J. Am. Med. Assoc, 195, 685, 1966.
Buss, D. H. Strongyliodes stercoralis infection complicating granulocytic leukemia. N. C. Med. J, 32, 269, 1971.
Civantos, F. and Robinson, M. J. Fatal strongyloidiasis following corticosteroid therapy. Am. J. Dig. Dis, 14, 643, 1969.
Cahill, K. M. Thiabendazole in massive strongyloidiasis. Am. J. Trop. Med. Hyg, 16, 451, 1967.
Amir-Ahmadi, H., Braun, P., Neva, F. A., Gottlieb. L. S., and Zamcheck, N. Strongyloidiasis at the Boston City Hospital. Am. J. Dig. Dis, 13, 959, 1968.
Smith, S. B., Schwartzman, M., Mencia, L. F., et al. Fatal disseminated strongyloidiasis presenting as acute abdominal distress in an urban child. J. Pediatr, 91, 607, 1977.
Seabury, J. H., Abadie, S., and Savoy, F. Jr. Pulmonary strongyloidiasis with lung abscess: ineffectiveness of thiabendazole therapy. Am. J. Trop. Med. Hyg, 20, 209, 1971.
Cuni, L., Rosner, F., and Chawla, S. K. Fatal strongyloidiasis in immunosuppressed patients. NY State J. Med, 77, 2109, 1977.
Cummins, R. O., Suratt, P. M., and Horwitz, D. A. Disseminated Strongyloides stercoralis infection. Arch. Intern. Med, 138, 1005, 1978.
Berger, R., Kraman, S., and Paciotti, M. Pulmonary strongyloidiasis complicating therapy with corticosteroids. Am. J. Trop. Med. Hyg, 29, 31, 1980.
Milder, J. E., Walzer, P. D., Kilgore, G., Rutherford, I., and Klein, M. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology, 80, 1481, 1981.
Cookson, J. B., Montgomery, R. D., Morgan, H. V., and Tudor, R. W. Fatal paralytic ileus due to strongyloidiasis. Br. Med. J, 4, 771, 1972.
Huchton, P. and Horn, R. Strongyloidiasis. J. Pediatr, 55, 602, 1959.
Faust, E. C. and DeGroat, A. Internal autoinfection in human strongyloidiasis. Am. J. Trop. Med, 20, 359, 1940.
Galliard, H. Pathogenesis of Strongyloides. Helminthol. Abstr, 36, 247, 1967.
Purtilo, D. T., Meyers, W. M., and Connor, D. H. Fatal strongyloidiasis in immunosuppressed patients. Am. J. Med, 56, 488, 1974.
Adam, M., Morgan, O., Persaud, C., and Gibbs, W. N. Hyperinfection syndrome, with Strongyloides stercoralis in malignant lymphoma. Br. Med. J, 1, 264, 1973.
Ali-Khan, Z. and Seemayer, T. A. Fatal bowel infaction and sepsis: an unusual complication of systemic strongyloidiasis. Trans. R. Soc. Trop. Med. Hyg, 69, 473, 1975.
Brown, H. W. and Perna, V. P., An overwhelming Strongyloides infection. J. Am. Med. Assoc, 168, 1648, 1958.
Cruz, T., Reboucas, G., and Rocha, H. Fatal strongyloidiasis in patients receiving corticosteroids. N. Engl. J. Med, 275, 1093, 1966.
Kuberski, T. T., Gabor, E. P., and Boudreaux, D. Disseminated strongyloidiasis: a complication of the immunosuppressed host. West. J. Med, 122, 504, 1975.
Higenbottam, T. W. and Heard, B. E. Opportunistic pulmonary strongyloidiasis complicating asthma treated with steroids. Thorax, 31, 226, 1976.
Liepman, M. Disseminated Strongyloides stercoralis, a complication of immunosuppression. J. Am. Med. Assoc, 231, 287, 1975.
Cadham, F. T. Infestation with Strongyloides stercoralis associated with severe symptoms. Can. Med. Assoc. J, 29, 18, 1933.
Aziz, E. M. Strongyloides stercoralis infestation: review of the literature and report of 33 cases. South. Med. J, 62, 806, 1969.
Rojas, R. A. M. Pathology of Protozoal and Helminthic Diseases. Williams & Wilkins, Baltimore, 713, 1971.
Scaglia, M., Brustia, R., Gatti, S., et al. Autochthonous strongyloidiasis in Italy: an epidemiological and clinical review of 150 cases. Bull. Soc. Pathol. Exot. Filiales, 77, 328, 1984.
Genta, R. M., Gatti, S., Linke, M. J., Cevini, C., and Scaglia, M. Endemic strongyloidiasis in northern Italy: clinical and immunological aspects. Q. J. Med, 258, 679, 1988.
Davidson, R. A. Strongyloidiasis: a presentation of 63 cases. N. C. Med. J, 43, 23, 1982.
Davidson, R. A., Fletcher, R. H., and Chapman, L. E. Risk factros for strongyloidiasis: a case-control study. Arch. Intern. Med, 144, 321, 1984.
Rivera, E., Maldonado, N., Velez-Garcia, E., Grillo, A. J., and Malaret, G. Hyperinfection syndrome with Strongyloides stercoralis. Ann. Intern. Med, 72, 199, 1970.
Keller, R. and Keist, R. Protective immunity to Nippostrongylus brasiliensis in the rat: central role of the lymphocyte in worm expulsion. Immunology, 22, 767, 1972.
Neva, F. A. Biology and immunology of human strongyloidiasis. J. Infect. Dis, 153, 397, 1986.
Genta, R. M. Strongylodes stercoralis: immunobiological considerations on an unusual worm. Parasitology Today, 2, 241, 1986.
Wong, B. Parasitic diseases in immunocompromised hosts. Am. J. Med, 76, 479, 1984.
Longworth, D. L. and Weller, P. F. Hyperinfection syndrome with strongyloidiasis, in Current Clinical Topics in Infectious Diseases, Remington, J. S. and Swartz, M. N., Eds., McGraw-Hill, New York, 1, 1986.
Willis, A. J., P. and Nwokolo, C. Steroid therapy and strongyloidiasis. Lancet, 1, 1396, 1966.
Smith, J. W. Strongyloidiasis. Clin. Microbiol. Newsletter, 13, 33, 1991.
Armstrong, D. and Paredes, J. Strongyloidiasis, in Respiratory Disease in the Immunocompromised Host, Shalamer, J., Pizzo, P. A., Parrillo, J. E., and Masur, H., Eds. J. B. Lippincott, Philadelphia, 428, 1991.
Karolyi, Z., Eros, N., and Kriston, R. Cutaneous manifestations of strongyloidosis. Orv. Hetil 140, 191–194, 1999.
Hanck, Ch. and Holzer, B. R. Strongyloidiasis unter immunosuppressiver therapy. Schweiz. Med. Wcshr, 122, 899, 1992.
Stewart, J. B. and Heap, B. J. Fatal disseminated strongyloidiasis in an immunocompromised former war prisoner of the Japanese. J. R. Army Med. Corps,131, 47, 1985
Rivals, A., Rouquet, R. M., Recco, P., Linas, M. D., Leophonte, P., and Didier, A. A rare cause of asthma exacerbation: systemic anguilluliasis. Rev. Mal. Respir, 17, 99–102, 2000.
Thomas, M. C. and Costello, S. A. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int. J. Clin. Pract, 52, 520–521, 1998.
Suvajdzic, N., Kranjcic-Zec, I., Jovanovic, V., Popovic, D., and Colovic, M. Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia (Budap.), 29, 323–326, 1999.
Link, K. and Orenstein, R. Bacterial complications of strongyloidiasis: Streptococcus bovin meningitis. South Med. J, 92, 728–731, 1999.
Suvajdzic, N., Kranjcic-Zec, I., Jovanovic, V., Popovic, D., and Colovic, M. Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia (Budap), 29, 323–326, 1999.
Batoni, F. L., Ianhez, L. E., Saldanha, L. B., and Sabbaga, E. Acute respiratory insufficiency caused by disseminated strongyloidiasis in a renal transplant. Rev. Inst. Ned. Trop. Sao Paulo, 18, 283, 1976.
Fagundes, L. A., Busato, O., and Brentano, L. Strongyloidiasis: fatal complication of renal transplantation. Lancet, 2, 439, 1971.
Meyers, A. M., Shapiro, D. J., Milne, F. J., Myburgh, J. A., and Rabkin, R. Strongyloides stercoralis hyperinfection in a renal allograft recipient. S. Afr. Med. J, 50, 1301, 1976.
Scoggin, C. H. and Call, N. B. Acute respiratory failure due to disseminated strongyloidiasis in a renal transplant recipient. Ann. Intern. Med, 87, 456, 1977.
DeVault, G. A., King, J. W., Rohr, M. S., Landreneau, M. D., Brown, S.T. III, and McDonald, J. C., Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev. Infect. Dis, 12, 653, 1990.
Palau, L. A. and Pankey, G. A. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am. J. Trop. Med. Hyg, 57, 413–415, 1997.
Dwork, K. G., Jaffe, J. R., and Lieberman, H. D. Strongyloidiasis with massive hyperinfection. NY State J. Med, 75, 1230, 1975.
Neefe, L. I., Pinilla, O., Garagusi, V. F., and Bauer, H. Disseminated strongyloidiasis with cerebral involvement. Am. J. Med, 55, 832, 1973.
Said, S., Nevez, G., Moriniere, P., Fournier, A., and Raccurt, C. P. Hemodialyse et strongyloidose: une cause presumee d’hypereosinophilie peut en cacher une autre. Nephrologie, 20, 343–346, 1999.
Ho, P. L., Luk, W. K., Chan, A. C., and Yuen, K. Y. Two cases of fatal stroingyloidiasis in Hong Kong. Pathology, 29, 324–326, 1997.
Emad, A. Exudative eosinophilic pleural effusion due to Strongyloides stercoralis in a diabetic man. South. Med. J, 92, 58–60, 1999.
Bozikov, V., Dzebro, S., Seidle, K., Dominis, M., Zambal, Z., and Skrabalo, Z. Fatal “overwhelming” strongyloidiasis in an immunosuppressed patient. Lijec Vjesn, 118, 23–26, 1996.
Nagalotimath, S. J., Ramaprasad, A. V., and Chandrashekhar, N. K. Fatal strongyloidiasis in a patient receiving corticosteroids. Indian J. Pathol. Bacteriol, 17, 190, 1974.
Yim, Y., Kikkawa, Y., Tanowitz, H., and Wittner, M. Fatal strongyloidiasis in Hodgkin’s disease after immunosuppressive therapy. J. Trop. Med. Hyg, 73, 245, 1970.
Rassiga, A. L., Lowry, J. L., and Forman, W. B. Diffuse pulmonary due to Strongyloides stercoralis. J. Am. Med. Assoc, 230, 426, 1974.
Suzuki, T., Nara, N., Miyake, S., Eishi, Y., Sugiyama, E, and Aoki, N. Fatal strongyloidiasis latent over 42 years in the antineoplastic chemotherapy of a case with malignant lymphoma. Jpn. J. Med, 28, 96, 1989.
Patil, P., Jayshree, R. S., Acharya, R. S., Sridhar, H., Babu, G., and Suresh, T. M. Fulminant fatal Strongylides stercoralis infection in a post-chemotherapy immunosuppressed cancer patient. Med. Pediatr. Oncol, 33, 504–555, 1999.
Daubenton, J. D., Buys, H. A., and Hartley, P. S. Disseminated strongyloidiasis in a child with lymphoblastic lymphoma. J. Pediatr. Hematol. Oncol, 20, 260–263, 1998.
Muller, A., Fatkenheuer, G., Salzberger, B., Schrappe, M., and Diehl, V. Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma. Dtsch. Med. Wochenschr, 123, 381–385, 1998.
Graeff-Teixeira, C., Leite, C. S., Sperhacke, C. L., et al. Prospective study of strongyloidosis in patients with hematologic malignancies. Rev. Soc. Bras. Med. Trop, 30, 355–357, 1997.
Hartz, P. H. Human strongyloidiasis with internal autoinfection. Arch. Pathol, 41, 601, 1946.
Yoeli, M., Most, H., Berman, H. H., and Scheinesson, G. P., II. The clinical picture and pathology of a massive Strongyloides infection in a child. Trans. R. Soc. Trop. Med. Hyg, 57, 346, 1963.
Bistrian B. R., Sherman, M., Blackburn, G. L., Marshall, R., and Shaw, C. Cellular immunity in adult marasmus. Arch. Intern. Med, 137, 1408, 1977.
Gage, J. G. A case of Strongyloides intestinalis with larvae in the sputum. Arch. Intern. Med, 7, 561, 1911.
Tullis, D. C. H. Bronchial asthma associated with intestinal parasites. N. Engl. J. Med, 282, 370, 1970.
Giannella, R. A., Broitman, S. A., and Zamcheck, N. Influence of gastric acidity on bacterial and parasitic enteric infections. Ann. Intern. Med, 78, 271, 1973.
Shikhobalova, N. P. and Semenova, N. E. On the problem of the clinical study and treatment of strongyloidiasis. Trop. Dis. Bull, 41, 411, 1944.
Parana, R., Portugal, M., Vitvitski, L., Cotrim, H., Lyra, L., and Trepo, C. Severe strongyloidiasis during interferon plus ribavirin therapy for chronic HCV infection. Eur. J. Gastroenterol. Hepatol, 12, 245–246, 2000.
Gompels, M., Todd, J., Peters, B., Main, J., and Pinching, A. J. Disseminated strongyloidiasis in AIDS: uncommon but important. AIDS, 5, 329, 1991.
Torres, J. R., Isturiz, R., Murillo, J., Guzman M., and Contreras, R. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin. Infect. Dis, 17, 900, 1993.
Heath, T., Riminton, S., Garsia, R., and Macleod, C. Systemic strongyloidiasis complicating HIV: a promising response to ivermectin. Int. J. STD AIDS, 7, 294–296, 1996.
Chieffi, P. P., Chiattone, C. S., Feltrim, E. N., Alves, R. C., and Paschoalotti, M. A. Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in Sao Paulo City, Brazil. Mem. Inst. Oswaldom Cruz, 95, 711–712, 2000.
Sorensen, M., Andersen, O., Friis-Moller, A., and Kvinesdal, B. B. Fatal outcome of Strongyloides stercoralis infection in a patient with no previously known immunosuppression. Ugeskr. Laeger, 162, 2894–2895, 2000.
Oya, H., Mori, S., Tsuchihashi, H., et al. A case of pleuritis caused by strongyloides in a carrier of T-cell lymphoma virus type I (HTLV-I). Nihon Kokyuki Gakkai Zasshi, 36, 262–267, 1998.
Bonnet, C., Vergne, P., Bertin, P., and Treves, R. Anguillulose associee a une infection par HTLV1. Presse Med, 28, 788, 1999.
Gotuzzo, E., Terashima, A., Alvarez, H., et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am. Trop. Med. Hyg, 60, 146–149, 1999.
Nakada, K., Kohakura, M., Komoda, H., and Hinuma, Y. High incidence of HTLV-I antibody in carriers of Strongyloides stercoralis. Lancet, 1, 633, 1984.
Higashiyama, Y., Sakata, H., Obase, Y., et al. A case of bacterial emningitis induced by strongyloidiasis. Kansenshogaku Zasshi, 71, 680–683, 1997.
Foucan, L., Genevier, I., Lamaury, I., and Strobel, M. Meningite purulente aseptique chez deux patients co-infectes par HTLV-1 et Strongyloides stercoralis. Med. Trop. (Mars.), 57, 262–264, 1997.
Newton, R. C., Limpuangthip, P., Greenberg, S., Gam, A., and Neva, F. A. Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. Am. J. Med, 92, 202, 1992.
Yamaguchi, K., Matutes, E., Catovsky, D., Galton D. A. G., Nakada, K., and Takatsuki, K. Strongyloides stercoralis as candidate co-factor for HTLV-1-induced leukaegenesis. Lancet, 2, 94, 1987.
Maayan, S., Wormser, G. P., Widerhorn, J., Sy, E. R., Kim, Y. H., and Ernst, J. A. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am. J. Med, 83, 945, 1987.
Vieyra-Herrera, G., Becerril-Carmona, G., Padua-Gabriel, A., Jessurun, J., and Alonso-de Ruiz, P. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Acta Cytologica, 32, 277, 1988.
Pialoux, G., Beriel, P., Caudron, J., Chousterman, M., and Meyrignac, C. Syndrome d’imminodépression acquise associé a une anduillulose sévere. Presse Med, 13, 1960, 1984.
René, E., Marche, C., Régnier, B., et al. Manifestations digestives du syndrome d’immunodéficience acquise (SIDA): étude chez 26 patients. Gastroenterol. Clin. Biol, 9, 327, 1985.
Baird, J. K., De Vinatea, M. L., Macher, A. M., Sierra, J. A. R., and Lasala, G. AIDS: case for diagnosis series. Milit. Med, 152, M17, 1987.
Hillyer, G. V. and Climent, C. Acquired immunodeficiency syndrome (AIDS) and parasitic disease in Puerto Rico. Bol. Asoc. Med. PR, 80, 312, 1988.
Petithory, J. C. and Derouin, F. AIDS and strongyloidiasis in Africa. Lancer, 1, 921, 1987.
Gachot, B., Bouvet, E., Bure, A., et al. HIV infection and malignant strongyloidiasis. Rev. Prat, 40, 2129, 1990.
Goyal, S. B. Intestinal strongyloidiasis as eosinophilic pleural effusion. South. Med. J, 91, 768–769, 1998.
Weight, S. C. and Barrie, W. W. Colonic Strongyloides stercoralis infection masquerading as ulcerative colitis. J. R. Coll. Surg. Edinb, 42, 202–203, 1997.
Ting, Y. M. Pulmonary strongyloidiasis; case report of 2 cases. Kaohsiung J. Med. Sci, 16, 269–274, 2000.
Kinjo, T., Tsuhako, K., Nakazato, I., et al. Extensive intra-alveolar haemorrhage caused by disseminated strongyloidiasis. Int. J. Parasitol, 28, 323–330, 1998.
Woodring, J. H., Halfhill, H. 2nd, Berger, R., Reed, J. C., and Moser, N. Clinical and imaging features of pulmonary strongyloidiasis. South. Med. J, 89, 10–19, 1996.
Levy, G. C., Kallas, E. G., and Ramos Moreira Leite, K. Disseminated Strongyloides stercoralis infection in an AIDS patient: the role of suppressive therapy. Braz. J. Infect. Dis, 1, 48–51, 1997.
Kiyuna, M., Toda, T., Tamamoto, T., et al. An autopsy case of periarteritis nodosa associated with disseminated strongyloidiasis. Rinsho Byori, 42, 883, 1994.
Jacob, C. I. and Patten, S. F. Strongyloides stercoralis infection presenting as generalized prurigo nodularis and lichen simplex chronicus. J. Am. Acad. Dermatol, 41 (2 Pt. 2), 357–361, 1999.
Mori, S., Konishi, T., Matsuoka, K., et al. Strongyloidiasis associated with nephritic syndrome. Intern. Med, 37, 606610, 1998.
Wong, T. Y., Szeto, C. C., Lai, F. F., Mak, C. K., and Li, P. K. Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents. Nephron, 79, 333–336, 1998.
Brocq, O., Breul, V., Agopian, V., et al. Reactive arthritis induced by Strongyloides stercoralis. Rev. Rhum. Engl. Ed, 63, 217–219, 1996.
Genta, R. M., Douce, R. W., and Walzer, P. D. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J. Clin. Microbiol, 23, 1099, 1986.
Pearson, R. D. and Guerrant, R. L. Strongyloides infections, in Hunter’s Tropical Medicine, 7th ed., Strickland, G. T., Ed. W. B. Saunders, Philadelphia, 706, 1991.
Spry, C. J. F. Eosinophils: A Comprehensive Review, and Guide to the Scientific and Medical Literature. Oxford University Press, Oxford, 1988.
Moro-Furlani, A. M. and Krieger, H. Familial analysis of eosinophilia caused by helminthic parasites. Genet. Epidemiol, 9, 185, 1992.
Fisher, D., McCary, F., and Currie, B. Strongyloidiasis in the Northern Territory. Med. J. Aust, 159, 88, 1993.
Prociv, P. Strongyloidiasis in the Northern Territory. Med. J. Aust, 159, 636, 1993.
Savage, D., Foadi, M. Haworth, C., and Grant, A. Marked eosinophilia in an immunosuppressed patient with strongyloidiasis. J. Intern. Med, 236, 473, 1994.
Sher, A. and Coffman, R. L. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol, 10, 385, 1992.
Thomson, A. W., Mathie, I. H., and Sewell, H. F. Cyclophosphamide-induced eosinophilia in the rat: concomitant changes in T-cell subsets, B cell and large granular lymphocytes within lymphoid tissues. Immunology, 60, 383, 1987.
Gherman, I., Oproiu, A., Aposteneau, G., et al. Observations on 35 cases of strongyloidiasis hospitalized at a clinical digestive disease unit. Rev. Med. Interna, 41, 169, 1989.
Stey, C., Jost, J., and Lüthy, R. Extraintestinale strongyloidiasis bei erworbenem immunmangelsyndrom. Dtsch. Med. Wschr, 115, 1716, 1990.
Azab, M. E., Mohamed, N. H., Salem, S. A., et al. Parasitic infections associated with malignancy and leprosy. J. Egypt. Soc. Parasitol, 22, 59, 1992.
Harley, J. P. and Gallicchio, V. Effect of cortisone on the establishment of Nippostrongylus brasiliensis in the rabbit. J. Parasitol, 56, 271, 1970.
Moqbel, R. Effect of corticosteroids on experimental strongyloidiasis. Proc. Br. Soc. Parasitology. Parasitology, 69, xviii, 1974.
Ogilvie, B. M. Use of cortisone derivatives to inhibit resistance to Nippostrongylus brasiliensis and to study the fate of parasites in resistant hosts. Parasitology, 55, 723, 1965.
Franz, K. H. Clinical trials with thiabendazole against human strongyloidiasis. Am. J. Trop. Med. Hyg, 12, 211, 1963.
Most, H. Treatment of common parasitic infections of man encountered in the United States (first of two parts). N. Engl. J. Med, 287, 495, 1972.
Wehner, J. H. and Kirsch, C. M. Pulmonary manifestations of strongyloidiasis. Semir. Respir. Infect, 12, 122–129, 1997.
Gordon, S. M., Gal, A. A., Solomon, A. R., and Bryan, J. A. Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host. J. Am. Acad. Dermatol, 31, 255, 1994.
Kramer, M. R., Gregg, P., Goldstein, M., Llamas, R., and Krieger, B. P. Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: diagnosis by sputum and bronchoalveolar lavage. South. Med. J, 83, 1226, 1990.
Schumaker, J. D., Band, J. D., Lensmeyer, G. L., and Craig, W. A. Thiabendazole treatment of severe strongyloidiasis in a hemodialyzed patient. Ann. Intern. Med, 89, 644, 1978.
Royle, G., Fraser-Moodie, A., and Jones, M. W. Hyperinfection with Strongyloides stercoralis in Great Britain. Br. J. Surg, 61, 498, 1974.
Eland, I. A., Kerkhof, S. C., Overbosch, D., Wismans, P. J., and Stricker, B. H. Cholestatic hepatis ascribed to the use of thiabendazole. Ned. Tijdschr. Geneeskd, 142, 1331–1334, 1998.
Skandrani, K., Richardet, J. P., Duvoux, C., Cherqui, D., and Zafrani, E. S. Hepatic transplantaion for severe ductopenia related to ingestion of thiabendazole. Gastroenterol. Clin. Biol, 21, 623–625, 1997.
Bush, A., Gabriel, R., Gatus, S. J., and Thornton, J. G. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft patient. Br. Med. J, 286, 52, 1983.
Cook, G. A., Rodriguez, A., Silva, H., Rodriguez-Iturbe, B., and Bohorquez de Rodriguez, H. Adult respiratory distress secondary to strongyloidiasis. Chest, 92, 1115, 1987.
Thomson, J. R. and Berger, R. Fatal adult respiratory distress syndrome following successfull treatment of pulmonary strongyloidiasis. Chest, 99, 772, 1991.
Berger, R., Kramm, S, and Paciotti, M. Pulmonary strongyloidiasis complicating therapy with corticosteroids. Am. J. Trop. Med. Hyg, 29, 31, 1980.
Thomson, J. R. and Berger, R. Strongyloides stercoralis infection: a review of 66 cases. South. Med. J, 82 (Suppl.), 7, 1989.
Bidulph, J. Mebendazole and albendazole for infants. Pediatr. Infect. Dis. J, 5, 373, 1990.
Currie, B. Why does Australia have no national drug policy? Med. J. Aust, 157, 210, 1992.
Sreenivas, D. V., Kumar, A., Kumar, Y. R., Bharavi, C., Sundaram, C., and Gayathri, K., Intestinal strongyloidiasis; a rare opportunistic infection. Indian J. Gastroenterol, 16, 105–106, 1997.
Nandy, A., Addy, M., Patra, P., and Bandyopashyay, A. K. Fulminating strongyloidiasis complicating Indian kala-azar. Trop. Geogr. Med, 47, 139, 1995.
Naquira, C., Jimenez, G., Guerra, J. G., et al. Ivermectin for human strongyloidiasis and other intestinal helminthes. Am. J. Trop. Med. Hyg, 40, 304, 1989.
Adenusi, A. A. Cure by ivermectin of a chronic, persistent intestinal strongyloidosis. Acta Trop, 66, 163–167, 1997.
Ashraf, M., Gue, C. L., and Baddour, L. M., Case report: strongyloidiasis refractory to treatment with ivermectin. Am. J. Med. Sci, 311, 178–179, 1996.
Giannoulis, E., Arvanitakis, C., Zaphirolopoulos, A., Nakos, V., Karkavelas, G., and Haralambidis, S. Disseminated strongyloidiasis with uncommon manifestations in Greece. J. Trop. Med. Hyg, 89, 171, 1986.
Zaha, O., Hirata, T., Kinjo, F., and Saito, A. Strongyloidiasis–progress in diagnosis and treatment. Intern. Med, 39, 695–700, 2000.
Toma, H., Sato, Y., Siroma, Y., Kobayashi, J., Shimabukuro, I., and Takara, M. Comparative studies on the efiicacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J. Trop. Med. Public Health, 31, 147–151, 2000.
Marti, H., Haji, H. J., Savioli, L., et al. A comparative trial of a single-dose ivermectin versus theree days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg, 55, 477–481, 1996.
Pitisuttithum, P., Supanaranond, W., and Chindanond, D. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J. Trop. Med. Public Health, 26, 735–738, 1995.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Georgiev, V.S. (2003). Strongyloides stercoralis. In: Opportunistic Infections. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-296-8_17
Download citation
DOI: https://doi.org/10.1007/978-1-59259-296-8_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-303-9
Online ISBN: 978-1-59259-296-8
eBook Packages: Springer Book Archive